Carregant...
Avasimibe inhibits tumor growth by targeting FoxM1-AKR1C1 in osteosarcoma
BACKGROUND: Osteosarcoma (OS) is a rare bone tumor with a high propensity for lung metastasis and poor patient outcomes. It is crucial to identify novel therapeutic strategies and biomarkers. PATIENTS AND METHODS: ARK1C1 staining was detected in OS specimens, and its clinical significance was assess...
Guardat en:
| Publicat a: | Onco Targets Ther |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6353227/ https://ncbi.nlm.nih.gov/pubmed/30774369 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S165647 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|